Eagle Pharmaceuticals Inc.: Business Overview, Financials & Competitive Analysis
Eagle Pharmaceuticals Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). Eagle represents a profitable specialty pharma operator in a consolidating market, offering modest growth potential but exposed to generic erosion risks. Eagle maintains a focused niche strategy in specialty pharmaceuticals with modest profitability and cash generation. The company faces ongoing patent cliffs and generic competition but continues to develop.
What is Eagle Pharmaceuticals Inc.'s industry? Eagle Pharmaceuticals Inc. (eaglepharm.com) operates in Specialty Pharmaceuticals / Injectable Drugs. AskCyborg classifies Eagle Pharmaceuticals Inc. under Specialty Pharmaceuticals / Injectable Drugs in its company registry.
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing critical care and oncology drugs. The company primarily targets hospital-based markets with injectable medications,...
Cyborg Score thesis
Eagle represents a profitable specialty pharma operator in a consolidating market, offering modest growth potential but exposed...
Read the full analyst-debate transcript →Get the Latest Eagle Pharmaceuticals Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeEagle Pharmaceuticals Inc. Overview
Pro stress-test →Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing critical care and oncology drugs. The company primarily targets hospital-based markets with injectable medications, addressing unmet medical needs in acute care settings.
Strategic Profile
Pro stress-test →Eagle differentiates through its focus on niche hospital-based therapeutics where it can achieve pricing power and reduced generic competition. The company leverages its specialized distribution channels and relationships with hospital networks to establish barriers to entry and sustainable competitive advantages.
Competitive Landscape
Pro stress-test →Eagle competes with larger pharmaceutical companies (Pfizer, Teva, Baxter/Endo) and other specialty generic manufacturers in the injectable drug space. The company differentiates through therapeutic focus and hospital relationships rather than scale, competing primarily on specialty niche positioning.
Industry Context
Eagle Pharmaceuticals Inc. operates in Specialty Pharmaceuticals / Injectable Drugs.
Key facts
Founded: 1996 · Headquarters: Woodcliff Lake, New Jersey · Employees: 1,200 · Revenue: $600M-$700M